Shenzhen - Delayed Quote • CNY
CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ)
At close: May 31 at 3:04 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
2,307,046.37
2,501,699.91
2,626,488.83
1,849,677.01
1,317,414.12
--
Cost of Revenue
1,279,624.20
1,367,653.27
1,491,570.46
1,041,229.36
584,198.13
--
Gross Profit
1,027,422.17
1,134,046.64
1,134,918.37
808,447.65
733,215.99
--
Operating Expense
313,041.86
350,923.71
375,231.57
349,346.96
390,482.71
--
Operating Income
714,380.31
783,122.93
759,686.80
459,100.68
342,733.28
--
Net Non Operating Interest Income Expense
87,714.67
65,260.60
31,568.72
27,079.14
8,172.96
--
Pretax Income
836,592.16
891,787.26
851,372.27
477,990.62
365,218.62
--
Tax Provision
129,960.33
136,469.71
124,760.60
85,290.03
65,506.43
--
Net Income Common Stockholders
705,316.23
755,557.25
726,277.89
393,228.49
299,835.76
--
Basic EPS
0.51
0.54
0.54
0.29
0.25
--
Diluted EPS
0.51
0.54
0.54
0.29
0.25
--
Basic Average Shares
1,396,924.46
1,387,829.03
1,336,912.83
1,336,964.49
1,179,681.67
--
Diluted Average Shares
1,396,924.46
1,387,829.03
1,336,912.83
1,336,964.49
1,179,681.67
--
Total Operating Income as Reported
836,277.31
891,346.64
855,588.02
487,364.95
360,022.20
--
Rent Expense Supplemental
--
--
--
850.17
1,574.11
1,305.46
Total Expenses
1,592,666.06
1,718,576.98
1,866,802.03
1,390,576.33
974,680.84
--
Net Income from Continuing & Discontinued Operation
705,316.23
755,557.25
726,277.89
393,228.49
299,835.76
--
Normalized Income
705,324.66
751,438.30
732,850.63
398,776.72
297,085.29
--
Interest Income
84,438.06
65,900.37
32,747.66
27,295.54
8,593.50
--
Interest Expense
154.05
355.57
219.23
58.60
--
--
Net Interest Income
87,714.67
65,260.60
31,568.72
27,079.14
8,172.96
--
EBIT
836,746.21
892,142.83
851,591.50
478,049.22
365,218.62
--
EBITDA
836,746.21
992,240.17
924,535.72
547,201.47
418,635.70
--
Reconciled Cost of Revenue
1,279,624.20
1,367,653.27
1,491,570.46
1,041,229.36
584,198.13
--
Reconciled Depreciation
--
100,097.34
72,944.22
69,152.26
53,417.08
--
Net Income from Continuing Operation Net Minority Interest
705,316.23
755,557.25
726,277.89
393,228.49
299,835.76
--
Total Unusual Items Excluding Goodwill
-9.98
4,863.16
-7,701.29
-6,753.25
3,351.62
--
Total Unusual Items
-9.98
4,863.16
-7,701.29
-6,753.25
3,351.62
--
Normalized EBITDA
836,756.19
987,377.01
932,237.01
553,954.72
415,284.07
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-1.55
744.21
-1,128.55
-1,205.01
601.15
--
12/31/2019 - 3/22/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade